Mathalon Daniel H, Hoffman Ralph E, Watson Todd D, Miller Ryan M, Roach Brian J, Ford Judith M
Psychiatry Service, San Francisco VA Medical Center and Department of Psychiatry, University of California San Francisco, CA, USA.
Front Hum Neurosci. 2010 Jan 29;3:70. doi: 10.3389/neuro.09.070.2009. eCollection 2010.
Schizoaffective disorder (SA) is distinguished from schizophrenia (SZ) based on the presence of prominent mood symptoms over the illness course. Despite this clinical distinction, SA and SZ patients are often combined in research studies, in part because data supporting a distinct pathophysiological boundary between the disorders are lacking. Indeed, few studies have addressed whether neurobiological abnormalities associated with SZ, such as the widely replicated reduction and delay of the P300 event-related potential (ERP), are also present in SA. Scalp EEG was acquired from patients with DSM-IV SA (n = 15) or SZ (n = 22), as well as healthy controls (HC; n = 22) to assess the P300 elicited by infrequent target (15%) and task-irrelevant distractor (15%) stimuli in separate auditory and visual "oddball" tasks. P300 amplitude was reduced and delayed in SZ, relative to HC, consistent with prior studies. These SZ abnormalities did not interact with stimulus type (target vs. task-irrelevant distractor) or modality (auditory vs. visual). Across sensory modality and stimulus type, SA patients exhibited normal P300 amplitudes (significantly larger than SZ patients and indistinguishable from HC). However, P300 latency and reaction time were both equivalently delayed in SZ and SA patients, relative to HC. P300 differences between SA and SZ patients could not be accounted for by variation in symptom severity, socio-economic status, education, or illness duration. Although both groups show similar deficits in processing speed, SA patients do not exhibit the P300 amplitude deficits evident in SZ, consistent with an underlying pathophysiological boundary between these disorders.
分裂情感性障碍(SA)与精神分裂症(SZ)的区别在于病程中是否存在突出的情绪症状。尽管有这种临床差异,但SA和SZ患者在研究中常被合并,部分原因是缺乏支持这两种疾病之间存在明显病理生理界限的数据。事实上,很少有研究探讨与SZ相关的神经生物学异常,如广泛重复的P300事件相关电位(ERP)降低和延迟,在SA中是否也存在。从DSM-IV SA患者(n = 15)或SZ患者(n = 22)以及健康对照(HC;n = 22)获取头皮脑电图,以评估在单独的听觉和视觉“oddball”任务中,由不常见目标(15%)和任务无关干扰物(15%)刺激诱发的P300。与HC相比,SZ患者的P300波幅降低且延迟,这与先前的研究一致。这些SZ异常与刺激类型(目标与任务无关干扰物)或模态(听觉与视觉)无关。在所有感觉模态和刺激类型中,SA患者的P300波幅正常(显著大于SZ患者,与HC无差异)。然而,与HC相比,SZ和SA患者的P300潜伏期和反应时间均同样延迟。SA和SZ患者之间的P300差异不能用症状严重程度、社会经济地位、教育程度或病程的差异来解释。尽管两组在处理速度上都有类似缺陷,但SA患者没有表现出SZ中明显的P300波幅缺陷,这与这两种疾病之间潜在的病理生理界限一致。